Clinical Trials Browser

Phase 1/2 × Leflunomide × Clear all

NCT03709446 2025-07-08

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Phase 1/2 Active not recruiting

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms